TITLE

Capacity, Vulnerability, and Informed Consent for Research

AUTHOR(S)
Biros, Michelle
PUB. DATE
March 2018
SOURCE
Journal of Law, Medicine & Ethics;Spring2018, Vol. 46 Issue 1, p72
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article presents an overview for clinician investigators on the concepts of decision-making capacity and vulnerability as related to human subjects research. Tools for capacity assessment and unacknowledged sources of vulnerability are discussed, and the practical gaps in current informed consent requirements related to impaired capacity and potential vulnerability are described. Options are suggested for research discussions when full regulatory consent is not possible and an exception from informed consent does not apply.
ACCESSION #
128747355

 

Related Articles

  • Return of Genetic Research Results to Participants and Families: IRB Perspectives and Roles. Beskow, Laura M.; O'Rourke, P. Pearl // Journal of Law, Medicine & Ethics;Fall2015, Vol. 43 Issue 3, p502 

    We surveyed IRB chairs' perspectives on offering individual genetic research results to participants and families, including family members of deceased participants, and the IRB's role in addressing these issues. Given a particular hypothetical scenario, respondents favored offering results to...

  • Design Issues in E-Consent. Wilbanks, John // Journal of Law, Medicine & Ethics;Spring2018, Vol. 46 Issue 1, p110 

    Electronic informed consent represents an opportunity to redesign the way that participants understand and elect to enroll in clinical research studies. However, electronic consent faces certain barriers common to all informed consent processes and other barriers specific to the technical...

  • IRB Decision-Making with Imperfect Knowledge: A Framework for Evidence-Based Research Ethics Review. Anderson, Emily E.; DuBois, James M. // Journal of Law, Medicine & Ethics;Winter2012, Vol. 40 Issue 4, p951 

    Here we describe the five steps of evidence-based practice as applied to research ethics review and apply these steps to three exemplar dilemmas: incentive payments in substance abuse research; informed consent for biobanking; and placebo-controlled trials involving pregnant women in order to...

  • In Plain Sight: A Solution to a Fundamental Challenge in Human Research. Shepherd, Lois; Riley, Margaret Foster // Journal of Law, Medicine & Ethics;Winter2012, Vol. 40 Issue 4, p970 

    The physician-researcher conflict of interest has thus far eluded satisfactory solution. Most attempts to deal with it focus on improving informed consent. But those attempts are not successful and may even make things worse. Research subjects are already voluntarily undertaking the risks of...

  • Nanomedicine First-in-Human Research: Challenges for Informed Consent. King, Nancy M. P. // Journal of Law, Medicine & Ethics;Winter2012, Vol. 40 Issue 4, p823 

    Risks of harm, translational uncertainty, ambiguities in potential direct benefit, and long-term follow-up merit consideration in first-in-human research. Some nanomedical technologies have additional characteristics that should be addressed, including: defining and describing nanomedical...

  • Reducing Regulatory Burdens on Research with Human Subjects: A Case Study of the Transition to the Final Common Rule at Boston Medical Center and Boston University Medical Campus. Ennever, Fanny K. // Journal of Law, Medicine & Ethics;Spring2018, Vol. 46 Issue 1, p164 

    Boston Medical Center/Boston University Medical Campus recently reduced certain requirements for human subjects research where this could be done without adversely affecting the rights and welfare of participants, in anticipation of changes in the Final Common Rule. Modifications affected exempt...

  • Discrepancy between participants' understanding and desire to know in informed consent: are they informed about what they really want to know? Koh, Jiwon; Goh, Eurah; Yu, Kyung-Sang; Cho, Belong; Yang, Jeong Hee // Journal of Medical Ethics;Feb2012, Vol. 38 Issue 2, p102 

    Background Participants' understanding of clinical trials is important in informed consent. However, little is known about what information participants really want to know. Aims To demonstrate the existence of a discrepancy between participants' understanding and their desire to know. Methods...

  • Texas A&M IC information sheet template.  // IRB Advisor;Aug2013, Vol. 13 Issue 8, p91 

    The article presents the Texas A&M University's informed consent (IC) information sheet template. Questions included in the information sheet include why the study is being done, what the alternatives are to being in this study and whether the information from the study will be kept private. It...

  • Risk communication in practice: the contribution of decision aids. O'Connor, Annette M; Légaré, France; Stacey, Dawn // BMJ: British Medical Journal (International Edition);9/27/2003, Vol. 327 Issue 7417, p736 

    The authors investigate practical and effective approaches that medical personnel can use when counselling patients about informed consent and decision making. The goal in decision making is to select health services that increase the chances of valued health outcomes and that minimise the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics